epigallocatechin gallate has been researched along with Precancerous Conditions in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Erstad, DJ; Fuchs, BC; Fujii, T; Hirschfield, H; Hoshida, Y; Kim, RS; Lanuti, M; Lauwers, GY; Sojoodi, M; Tanabe, KK; Wei, L; Yamada, S | 1 |
| Elahl, HMS; Hassan, ESG; Hassanein, NMA; Hegab, AM | 1 |
| Baba, A; Kochi, T; Kubota, M; Moriwaki, H; Ohno, T; Shimizu, M; Shirakami, Y; Tanaka, T; Terakura, D; Tsurumi, H | 1 |
| Messadi, DV; Sato, K | 1 |
| Adachi, S; Hata, K; Hirose, Y; Moriwaki, H; Sakai, H; Shimizu, M; Shirakami, Y; Tanaka, T; Tsurumi, H | 1 |
| Banerjee, S; Das, S; Manna, S; Panda, CK; Roy, A; Saha, P | 1 |
| Bailey, GS; Carter, O; Dashwood, RH; Dashwood, WM; Fischer, KA; Löhr, CV; Orner, GA; Pereira, CB; Wang, R; Williams, DE | 1 |
| Guo, YC; Jiao, ZQ; Kan, B; Lü, XZ; Xu, Y | 1 |
| Araki, R; Inoue, S; Osborne, MP; Telang, NT | 1 |
| Chou, TC; Edelstein, D; Khafif, A; Sacks, PG; Schantz, SP | 1 |
| Hara, Y; Hasegawa, J; Isemura, M; Kishimoto, Y; Kohri, T; Miura, N; Ohishi, T; Shiota, G | 1 |
1 review(s) available for epigallocatechin gallate and Precancerous Conditions
| Article | Year |
|---|---|
Oral Cancer Chernoprevention: Current Status and Future Direction.
Topics: Anticarcinogenic Agents; Carcinogenesis; Carotenoids; Catechin; Chemoprevention; Humans; Mouth Neoplasms; Plant Preparations; Precancerous Conditions; Trypsin Inhibitor, Bowman-Birk Soybean; Trypsin Inhibitors | 2016 |
10 other study(ies) available for epigallocatechin gallate and Precancerous Conditions
| Article | Year |
|---|---|
Epigallocatechin Gallate Induces Hepatic Stellate Cell Senescence and Attenuates Development of Hepatocellular Carcinoma.
Topics: Animals; Anticarcinogenic Agents; Biomarkers; Carcinoma, Hepatocellular; Catechin; Cellular Senescence; Diethylnitrosamine; Hepatic Stellate Cells; Liver Cirrhosis; Liver Neoplasms, Experimental; Male; Phenotype; Precancerous Conditions; Rats; Tea; Transcriptome | 2020 |
Chemopreventive effect of sulindac in combination with epigallocatechin gallate or kaempferol against 1,2-dimethyl hydrazine-induced preneoplastic lesions in rats: A Comparative Study.
Topics: 1,2-Dimethylhydrazine; Animals; Anticarcinogenic Agents; beta Catenin; Carcinogens; Catechin; Colonic Neoplasms; Cyclooxygenase 2; Down-Regulation; Drug Therapy, Combination; Kaempferols; Male; Nitric Oxide; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Rats, Sprague-Dawley; Sulindac; Thiobarbituric Acid Reactive Substances | 2018 |
Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions.
Topics: Angiotensin II; Animals; Anticarcinogenic Agents; Catechin; Fatty Liver; Gene Expression; Hypertension; Interleukin-6; Lipid Peroxidation; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Peptidyl-Dipeptidase A; Precancerous Conditions; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Tumor Necrosis Factor-alpha | 2014 |
(-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Carcinoma; Catechin; Cholesterol; Colonic Neoplasms; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Insulin; Intestinal Mucosa; Leptin; Male; Mice; Mice, Inbred C57BL; Precancerous Conditions; Receptor, IGF Type 1; Triglycerides | 2008 |
Differential alterations in metabolic pattern of the spliceosomal UsnRNAs during pre-malignant lung lesions induced by benzo(a)pyrene: modulation by tea polyphenols.
Topics: Animals; Benzo(a)pyrene; Catechin; Flavonoids; Lung; Lung Neoplasms; Mice; Phenols; Polyphenols; Precancerous Conditions; RNA, Small Nuclear; Spliceosomes; Tea | 2006 |
Comparison of white tea, green tea, epigallocatechin-3-gallate, and caffeine as inhibitors of PhIP-induced colonic aberrant crypts.
Topics: Animals; Anticarcinogenic Agents; Caffeine; Carcinogens; Catechin; Cell Division; Colon; Colonic Neoplasms; Humans; Imidazoles; Male; Precancerous Conditions; Rats; Rats, Inbred F344; Tea | 2007 |
[Effects of cell growth and apoptosis of preneoplastic Syrian hamster embryo cells by green tea constituent epigallocatechin-3-gallate].
Topics: Animals; Apoptosis; Catechin; Cell Division; Cell Line, Tumor; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Female; Precancerous Conditions; Pregnancy; Tea | 2007 |
Chemoprevention of mammary preneoplasia. In vitro effects of a green tea polyphenol.
Topics: Animals; Anticarcinogenic Agents; Catechin; Cell Adhesion; Cell Division; Cell Line; Cell Transformation, Neoplastic; Cells, Cultured; Female; Genes, myc; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Precancerous Conditions; Tea; Transfection | 1995 |
Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells.
Topics: Anticarcinogenic Agents; Catechin; Cells, Cultured; Curcumin; Dose-Response Relationship, Drug; Drug Synergism; Epithelial Cells; Flow Cytometry; Humans; Mouth Neoplasms; Precancerous Conditions; Tea | 1998 |
Synergistic effects of (-)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Azoxymethane; Carcinogens; Catechin; Choristoma; Colon; Colonic Neoplasms; Drug Synergism; In Situ Nick-End Labeling; Incidence; Male; Nucleolus Organizer Region; Precancerous Conditions; Rats; Rats, Inbred F344; Sulindac; Tea | 2002 |